Peking University Engineers Tiny CRISPR Tool to Silence Hepatitis B
A newly engineered Cas12m variant fits into a single virus vector, enabling durable gene silencing in mouse models.
Key points
- The engineered xCas12m protein is small enough to fit inside a single adeno-associated virus vector.
- The system silences genes by modifying epigenetic markers rather than cutting DNA, reducing mutation risks.
- Mouse model tests showed the tool successfully suppressed hepatitis B virus activity.
Researchers at Peking University have developed a significantly smaller variant of the CRISPR protein that can silence genes without cutting DNA. This compact tool, named xCas12m, is designed to fit within the limited capacity of adeno-associated virus vectors, a common delivery method in gene therapy.
The study, reported by bioengineer.org, demonstrates that this miniature editor can suppress viral activity in a mouse model of hepatitis B. By avoiding double-strand breaks, the system aims to reduce the risk of unintended mutations while maintaining durable gene silencing in human cells.
Overcoming vector size limitations
Standard epigenetic editors are often too large to fit inside the viral carriers used for safe gene delivery. These carriers have a strict payload limit of about 4.7 kilobases, which previously forced scientists to use multiple, less efficient vectors. The new xCas12m system solves this by being small enough to include all necessary components in a single package.
This single-vector approach simplifies manufacturing and improves delivery efficiency. It addresses a major bottleneck in translating epigenome editing into clinical applications, where the ability to reach specific tissues safely is critical for therapeutic success.
How the miniature editor works
The team identified a naturally occurring enzyme from a bacterium that binds to DNA but lacks the ability to cut it. By characterizing this protein at the atomic level, they confirmed it serves as a stable scaffold for attaching chemical modifiers that adjust gene expression.
Unlike traditional CRISPR tools that act as molecular scissors, this system acts as a targeted delivery truck. It parks at a specific genomic address and releases enzymes that modify the surrounding environment, effectively turning genes down without altering the underlying DNA sequence.
Implications for viral treatment
In tests with mice infected with the hepatitis B virus, the engineered system successfully suppressed key measures of viral activity. This suggests a potential pathway for treating chronic viral infections by silencing the viral genome rather than attempting to remove it entirely.
The trade-off for this precision is that the effect relies on durable epigenetic changes. While this offers a safer alternative to DNA cutting, it requires careful monitoring to ensure the silencing remains specific and does not inadvertently affect nearby genetic regions.
